OTLK Stock Price | OUTLOOK THERAPEUTICS INC P/E, Revenue, EPS, & Forecasts

OUTLOOK THERAPEUTICS INC • OTLK

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About OUTLOOK THERAPEUTICS INC

Ticker

OTLK

Trading on

NASDAQ

ISIN

US69012T2069

Industry

Biotechnology

Sector

Healthcare

CEO

Lawrence A. Kenyon CPA

Headquarters

111 S. Wood Avenue, Iselin, NJ, United States, 08830

Employees

Website

outlooktherapeutics.com

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is headquartered in Iselin, New Jersey.

Metrics

BasicAdvanced

Market cap

$50.6M

P/E ratio

EPS

-$2.48

Dividend Yield

0.00%

Beta

0.47

Forward P/E ratio

2.85

EBIDTA

$-82.9M

Ex dividend date

Price & volume

Market cap

$50.6M

Average daily volume

0.4M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

2.85

PEG ratio

Trailing P/E

Price to sales

13.27

Price to book

10.19

Earnings

EPS

-$2.48

EPS estimate (current quarter)

-$0.52

EPS estimate (next quarter)

-$0.34

EBITDA

$-82.9M

Revenues (TTM)

$5.9M

Revenues per share (TTM)

$0.12

Technicals

Beta

0.47

52-week High

$9.29

52-week Low

$0.87

50-day moving average

$1.46

200-day moving average

$4.17

Short ratio

8.71

Short %

15.15%

Management effectiveness

ROE (TTM)

3.65%

ROA (TTM)

268.11%

Profit margin

0.00%

Gross profit margin

$-46.9M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

658.30%

Share stats

Outstanding Shares

32.6M

Float

20.4M

Insiders %

36.42%

Institutions %

16.08%

Analyst Insights & forecasts

84% Buy

16% Hold

0% Sell

Based on information from 6 analysts.

Average price target

$10.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$1.55

-$0.85

82.35%

Q1 • 24Beat

-$0.83

-$1.01

17.82%

Q2 • 24Beat

-$0.94

-$0.90

4.10%

Q3 • 24Beat

-$0.89

-$0.52

71.15%

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$5.7M

∞%

Q3 • 24

$0.2M

$17.4M

10,214.68%

Q4 • 24

∞%

205.34%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$28.8M

$102M

353.53%

Q3 • 24

$17T

$67.3T

395.72%

Q4 • 24

59,001,302.14%

66,041,824.34%

11.93%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-17M

$-0.1M

$-17M

Q3 • 24

$-11T

$1.74T

$-11T

Q4 • 24

64,582,415.67%

1,515,713,341.82%

64,582,415.67%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a OUTLOOK THERAPEUTICS INC share?

OUTLOOK THERAPEUTICS INC shares are currently traded for undefined per share.

How many shares does OUTLOOK THERAPEUTICS INC have?

OUTLOOK THERAPEUTICS INC currently has 32.6M shares.

Does OUTLOOK THERAPEUTICS INC pay dividends?

No, OUTLOOK THERAPEUTICS INC doesn't pay dividends.

What is OUTLOOK THERAPEUTICS INC 52 week high?

OUTLOOK THERAPEUTICS INC 52 week high is $9.29.

What is OUTLOOK THERAPEUTICS INC 52 week low?

OUTLOOK THERAPEUTICS INC 52 week low is $0.87.

What is the 200-day moving average of OUTLOOK THERAPEUTICS INC?

OUTLOOK THERAPEUTICS INC 200-day moving average is $4.17.

Who is OUTLOOK THERAPEUTICS INC CEO?

The CEO of OUTLOOK THERAPEUTICS INC is Lawrence A. Kenyon CPA.

How many employees OUTLOOK THERAPEUTICS INC has?

OUTLOOK THERAPEUTICS INC has 23 employees.

What is the market cap of OUTLOOK THERAPEUTICS INC?

The market cap of OUTLOOK THERAPEUTICS INC is $50.6M.

What is the P/E of OUTLOOK THERAPEUTICS INC?

The current P/E of OUTLOOK THERAPEUTICS INC is null.

What is the EPS of OUTLOOK THERAPEUTICS INC?

The EPS of OUTLOOK THERAPEUTICS INC is -$2.48.

What is the PEG Ratio of OUTLOOK THERAPEUTICS INC?

The PEG Ratio of OUTLOOK THERAPEUTICS INC is null.

What do analysts say about OUTLOOK THERAPEUTICS INC?

According to the analysts OUTLOOK THERAPEUTICS INC is considered a buy.